Literature DB >> 10814514

Phosphofructokinase C isozyme from ascites tumor cells: cloning, expression, and properties.

C Sánchez-Martínez1, A M Estévez, J J Aragón.   

Abstract

The phosphofructokinase C isozyme (PFK-C) from ascites tumor cells has been cloned and characterized to investigate the particular properties of PFK activity in this type of cells. The isolated cDNA encodes a protein of 784 amino acids and 85.5 kDa, whose expression was constant along tumor growth and markedly decreased when cell proliferation stops. The enzyme was functionally expressed in a PFK-deficient strain of Saccharomyces cerevisiae and purified to homogeneity. Recombinant PFK-C exhibited the same subunit size as the tumor wild-type isozyme and its steady-state kinetic parameters were similar to those of the form present in normal cells. The regulatory properties of the C isozyme accounted for the lack of fructose-1,6-P(2) activation and the P-enolpyruvate inhibition of PFK activity observed in ascites tumor preparations containing the various isozyme types. Nevertheless, PFK-C binds fructose-1,6-P(2) to an allosteric site as suggested by protection against thermal denaturation. Our results indicate that glucose metabolism in tumor cells is not regulated by a mutant form of PFK-C but by a high level expression of the normal C isozyme. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814514     DOI: 10.1006/bbrc.2000.2681

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.

Authors:  Edward Sanders; Svenja Diehl
Journal:  Oncoscience       Date:  2015-02-17

2.  Krüppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer.

Authors:  Jong-Seok Moon; Hee Eun Kim; Eunjin Koh; Se Ho Park; Won-Ji Jin; Byeong-Woo Park; Sahng Wook Park; Kyung-Sup Kim
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

3.  Slow oscillations persist in pancreatic beta cells lacking phosphofructokinase M.

Authors:  Isabella Marinelli; Vishal Parekh; Patrick Fletcher; Benjamin Thompson; Jinhua Ren; Xiaoqing Tang; Thomas L Saunders; Joon Ha; Arthur Sherman; Richard Bertram; Leslie S Satin
Journal:  Biophys J       Date:  2022-02-05       Impact factor: 4.033

4.  Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520.

Authors:  Yun-Yong Park; Sang-Bae Kim; Hee Dong Han; Bo Hwa Sohn; Ji Hoon Kim; Jiyong Liang; Yiling Lu; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Gordon B Mills; Anil K Sood; Ju-Seog Lee
Journal:  Hepatology       Date:  2013-05-15       Impact factor: 17.425

5.  Identification of C-terminal motifs responsible for transmission of inhibition by ATP of mammalian phosphofructokinase, and their contribution to other allosteric effects.

Authors:  Oscar H Martínez-Costa; Carmen Hermida; Cristina Sánchez-Martínez; Belén Santamaría; Juan J Aragón
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

6.  Subunit interactions and composition of the fructose 6-phosphate catalytic site and the fructose 2,6-bisphosphate allosteric site of mammalian phosphofructokinase.

Authors:  Cristina Ferreras; Eloy D Hernández; Oscar H Martínez-Costa; Juan J Aragón
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

7.  Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations.

Authors:  Bradley A Webb; Farhad Forouhar; Fu-En Szu; Jayaraman Seetharaman; Liang Tong; Diane L Barber
Journal:  Nature       Date:  2015-05-18       Impact factor: 49.962

Review 8.  6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.

Authors:  Mei Yi; Yuanyuan Ban; Yixin Tan; Wei Xiong; Guiyuan Li; Bo Xiang
Journal:  Mol Metab       Date:  2018-12-05       Impact factor: 7.422

9.  Selective activation of PFKL suppresses the phagocytic oxidative burst.

Authors:  Neri Amara; Madison P Cooper; Maria A Voronkova; Bradley A Webb; Eric M Lynch; Justin M Kollman; Taylur Ma; Kebing Yu; Zijuan Lai; Dewakar Sangaraju; Nobuhiko Kayagaki; Kim Newton; Matthew Bogyo; Steven T Staben; Vishva M Dixit
Journal:  Cell       Date:  2021-07-27       Impact factor: 41.582

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.